Lifecore Biomedical, Inc.
LFCR· Nasdaq
LFCRLifecore Biomedical, Inc.
Filed Mar 28, 2012 · 10-Q · 31 days after period end · 0001437749-12-002895
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $80.06M | $73.51M |
| Net Income | $4.77M | $2.30M |
| EPS Diluted | $0.18 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
ended Feb 26, 2012 · filed Mar 28, 2012 · 31 d after period end
